Skip to content
Screener

ADMA Biologics ADMA Vesting Of Restricted Stock Units Net Of Shares Withheld For Taxes Amount

Vesting Of Restricted Stock Units Net Of Shares Withheld For Taxes Amount at other companies

SelectQuote logo
SelectQuoteSLQT
-$1K+99.9%
Identive logo
IdentiveINVE
$350K+107%
Agrify Corporation logo
Agrify CorporationRYM
-$84.25K
Grid Dynamics Holdings, Inc. logo
Grid Dynamics Holdings, Inc.GDYN
-$3.99M+75.4%
Adeia logo
AdeiaADEA
-$3.11M+59.9%
Adeia logo
AdeiaADEA
-$3.11M+59.9%

Other financials

Income statement

See full
Revenue$124.4M+2.0%
Gross profit$86.3M+28.3%
Operating income$52.4M+22.5%
Net income$37.8M+10.5%
EPS (diluted)$0.16+14.3%

Balance sheet

See full
Cash & equivalents$136.0M+50.7%
Total debt$203.9M+1,855%
Total equity$408.2M+2.5%
Total assets$684.2M+22.5%

Cash flow

See full
Operating cash flow$29.5M+39.7%
CapEx$2.3M-6.9%
Free cash flow$27.3M+45.8%

Valuation

See full
Market cap$2.25B-49.1%
Enterprise value$2.32B-46.6%
P/E13.3×-7.9×
P/S4.4×-4.9×

Profitability

See full
Gross margin64.7%+11.7pp
Operating margin43.8%+11.0pp
Net margin33%-11.1pp
FCF margin22.7%+8.9pp

Returns & leverage

See full
Return on equity41.9%-29.3pp
Debt / equity0.5×+0.5×
Current ratio+1.6×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept adma:VestingOfRestrictedStockUnitsNetOfSharesWithheldForTaxesAmount.

The source filing: ADMA Biologics’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:16 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001140361-26-031445
Line itemCommon Stock / SharesCommon Stock / AmountAdditional / Paid-in / CapitalAccumulated / DeficitTreasury Stock / SharesTreasury Stock / AmountTotal / Stockholders' / Equity
Balance at December 31, 2025$239,793,566$24$671,039(161,653)$(1,919,070)$(32,090)477,320
Stock-based compensation--6,329---6,329
Cashless exercise of warrants-------
Vesting of Restricted Stock Units, net of shares withheld for taxes979,735-(8,362)---(8,362)
Exercise of stock options188,902-588---588
Acquisition of treasury stock--(19,798)-(6,754,156)(111,080)(130,878)
Net income---45,328--45,328
Balance at March 31, 2026240,962,20324649,796(116,325)(8,673,226)(143,170)390,325

Item 1. Financial Statements.

FAQ

What is ADMA Biologics's vesting of restricted stock units net of shares withheld for taxes amount?
ADMA Biologics (ADMA) reported vesting of restricted stock units net of shares withheld for taxes amount of -$625K in Q2 2026.
How has ADMA Biologics's vesting of restricted stock units net of shares withheld for taxes amount changed year-over-year?
ADMA Biologics's vesting of restricted stock units net of shares withheld for taxes amount increased by 47.6% year-over-year, from -$1.19M to -$625K.
What is the long-term trend for ADMA Biologics's vesting of restricted stock units net of shares withheld for taxes amount?
Over 2 years (2023 to 2025), ADMA Biologics's vesting of restricted stock units net of shares withheld for taxes amount has grown at a 159.7% compound annual growth rate (CAGR), from -$1.42M to -$9.55M.
What does vesting of restricted stock units net of shares withheld for taxes amount mean?
Vesting Of Restricted Stock Units Net Of Shares Withheld For Taxes Amount as reported by ADMA Biologics, Inc..

Ask your AI about ADMA Biologics's vesting of restricted stock units net of shares withheld for taxes amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude